$5.95 1%
ARDX Stock Price vs. AI Score (Last 150 days)
Data gathered: July 16

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Ardelyx

Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally.

Price $5.95
Target Price Sign up
Volume 2,550,000
Market Cap $1.41B
Year Range $3.56 - $9.74
Dividend Yield 0%
Revenue per Employee $1,155,128
Industry Biotechnology

In the news

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '2444M60M-16M-27M-24M-0.110
Q4 '2333M54M-20M-29M-26M-0.120
Q3 '2355M41M14M6.6M8.9M0.030
Q2 '2321M32M-10M-17M-15M-0.080
Q1 '2310M1.5M8.8M-27M-25M-0.130

Insider Transactions View All

RAAB MICHAEL filed to sell 1,267,963 shares at $6.6.
June 28 '24
Blanks Robert filed to sell 324,331 shares at $6.
June 25 '24
RAAB MICHAEL filed to sell 1,270,273 shares at $6.6.
June 17 '24
Williams Laura A filed to sell 422,152 shares at $7.1.
June 7 '24
Williams Laura A filed to sell 322,152 shares at $7.1.
June 7 '24

What is the Market Cap of Ardelyx?

The Market Cap of Ardelyx is $1.41B.

How Many People Work at Ardelyx?

As of our latest update, Ardelyx employed approximately 133 people worldwide. However, it's important to note that Ardelyx's workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Ardelyx's revenue per employee?

$1,155,128. To calculate Ardelyx's revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of Ardelyx?

Currently, the price of one share of Ardelyx stock is $5.95.

How can I analyze the ARDX stock price chart for investment decisions?

The ARDX stock price chart above provides a comprehensive visual representation of Ardelyx's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Ardelyx shares. Our platform offers an up-to-date ARDX stock price chart, along with technical data analysis and alternative data insights.

Does ARDX offer dividends to its shareholders?

As of our latest update, Ardelyx (ARDX) does not offer dividends to its shareholders. Investors interested in Ardelyx should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Ardelyx?

Some of the similar stocks of Ardelyx are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.